Talquetamab
Janssen
['multiplemyeloma', 'talquetamab', 'janssen']
#janssen presents new data for #talquetamab, a first-in-class #gprc5dxcd3 #bispecificantibody, suggesting durable responses in patients with heavily pretreated #multiplemyeloma #ash22 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.